Information
-
Trademark
-
90165171
-
Serial Number
90165171
-
Registration Number
6998642
-
International Classifications
-
Filing Date
September 08, 2020
4 years ago
-
Registration Date
March 14, 2023
a year ago
-
Transaction Date
March 14, 2023
a year ago
-
Status Date
March 14, 2023
a year ago
-
Published for Opposition Date
December 27, 2022
a year ago
-
Location Date
March 14, 2023
a year ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
FAUCETTE, MAX CLIFFORD
-
Attorney Docket Number
ASCNT-16-128
Attorney Name
Kathryn E. Smith
Law Office Assigned Location Code
L70
-
Owners
Mark Drawing Code
4000
Mark Identification
APGAVI
Case File Statements
- GS0051: Medicines for dental purposes; Chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antibiotics; Injectable medicines for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Medicine in tablet form for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs sold in bulk for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antiseptics; Collyrium; Hemorrhoidal suppositories, laxative suppositories, or vaginal suppositories for the prevention and treatment of infections; Medical paster, namely, medical plasters; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Medicated sweets; Candy for medical purposes; Dietetic foods adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic preparations adapted for medical purposes; Medicinal oils; Mineral food supplements; Nutritional supplements; Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Radioactive substances for medical purposes; Gases for medical purposes, namely, nitric oxide for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants; Solutions for contact lenses; Media for bacteriological cultures; Depuratives for the body; Diagnostic preparations for veterinary purposes; Pesticides; Sanitary napkins; Cotton for medical purposes; Dental abrasives; Diapers for pets
Case File Event Statements
-
3/14/2023 - a year ago
32 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
-
3/14/2023 - a year ago
31 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
12/27/2022 - a year ago
30 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
12/27/2022 - a year ago
29 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
12/7/2022 - 2 years ago
28 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
11/21/2022 - 2 years ago
27 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
10/21/2022 - 2 years ago
26 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
10/20/2022 - 2 years ago
25 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
10/20/2022 - 2 years ago
24 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/9/2022 - 2 years ago
23 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/9/2022 - 2 years ago
22 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/9/2022 - 2 years ago
21 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
5/18/2022 - 2 years ago
20 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
5/18/2022 - 2 years ago
19 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
5/17/2022 - 2 years ago
18 - ASSIGNED TO LIE
Type: ALIE
-
5/12/2022 - 2 years ago
17 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Type: ERSI
-
11/17/2021 - 3 years ago
16 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Type: GNS2
-
11/17/2021 - 3 years ago
15 - INQUIRY TO SUSPENSION E-MAILED
Type: GNSI
-
11/17/2021 - 3 years ago
14 - SUSPENSION INQUIRY WRITTEN
Type: CNSI
-
10/27/2021 - 3 years ago
13 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Type: RCCK
-
4/21/2021 - 3 years ago
12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
4/21/2021 - 3 years ago
11 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
4/21/2021 - 3 years ago
10 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
3/31/2021 - 3 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/30/2021 - 3 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
3/30/2021 - 3 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
1/6/2021 - 3 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
1/6/2021 - 3 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
1/6/2021 - 3 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
1/5/2021 - 3 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
10/13/2020 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
9/11/2020 - 4 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP